Do annexins participate in lipid messenger mediated intracellular signaling? A question revisited

Molecular Membrane Biology

Volumn 29, Issue 7, 2012, Pages 229-242

  Bandorowicz Pikula, Joanna ^a   Wos, Marcin ^a   Pikula, Slawomir ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Annexins; Lipid mediated signaling; Lipid metabolism; Membrane heterogeneity; Phospholipases

Indexed keywords

ANNEXIN; ANNEXIN A13; ANNEXIN A13B; CALCIUM ION; CALPHOBINDIN II; CERAMIDE; CERAMIDE 1 PHOSPHATE; CYTOSOLIC PHOSPHOLIPASE A2; ENDOCANNABINOID; GLUCOSYLCERAMIDE; LEUKOTRIENE; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 5; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROSTAGLANDIN; PROTEIN KINASE; RETINOL; SPHINGOSINE 1 PHOSPHATE; STEROID HORMONE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANNEXIN A1; ANNEXIN A2; CALCIUM; CELL MEMBRANE; CYTOSKELETON; HUMANS; LIPID METABOLISM; PHOSPHOLIPASES A2; SECOND MESSENGER SYSTEMS;

ANIMALIA;

EID: 84867923837     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2012.693210     Document Type: Review

References (156)

1. Astanina K, Delebinski CI, Delacour D, Jacob R. 2010. Annexin XIIIb guides raft-dependent and-independent apical traffic in MDCK cells. Eur J Cell Biol 89:799-806.
2. Ayala-Sanmartin J, Henry JP, Pradel LA. 2001. Cholesterol regulates membrane binding and aggregation by annexin 2 at submicromolar Ca2+ concentration. Biochim Biophys Acta 1510:18-28. (Pubitemid 32149882)
3. Ayoub SS, Yazid S, Flower RJ. 2008. Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1. Br J Pharmacol 154:1135-1142. (Pubitemid 351915065)
4. Babiychuk EB, Draeger A. 2000. Annexins in cell membrane dynamics. Ca2+-regulated association of lipid microdomains. J Cell Biol 150:1113-1124.
5. Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, Trugnan G, et al. 2004. Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence. Biochem J 378:307-315. (Pubitemid 38367221)
6. Balcerzak M, Bandorowicz-Pikula J, Buchet R, Pikula S. 2006. A novel retinoid binding property of human annexin A6. FEBS Lett 580:3065-3069. (Pubitemid 43729689)
7. Baron S, Vangheluwe P, SepúlvedaMR,Wuytack F,Raeymaekers L, Vanoevelen J. 2010. The secretory pathway Ca2+-ATPase 1 is associated with cholesterol-rich microdomains of human colon adenocarcinoma cells. Biochim Biophys Acta 1798: 1512-1521.
8. Barrientos G, Hidalgo C. 2002. Annexin VI is attached to transverse-tubule membranes in isolated skeletal muscle triads. J Membr Biol 188:163-173. (Pubitemid 34804260)
9. Bensalem N, Ventura AP, Vallée B, Lipecka J, Tondelier D, Davezac N, et al. 2005. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 4:1591-1601. (Pubitemid 41555482)
10. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, Persico P. 1980. Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287: 147-150.
11. Blume KE, Soeroes S, Keppeler H, Stevanovic S, Kretschmer D, Rautenberg M, et al. 2012. Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic 'find-me' signal. J Immunol 188:135-145.
12. Borot F, Vieu DL, Faure G, Fritsch J, Colas J, Moriceau S, et al. 2009. Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells. PLoS One 4:e7116.
13. Buckland AG, Wilton DC. 1998a. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2. Biochim Biophys Acta 1391:367-376. (Pubitemid 28202133)
14. Buckland AG, Wilton DC. 1998b. Inhibition of human cytosolic phospholipase A2 by human annexin V. Biochem J 329: 369-372. (Pubitemid 28040801)
15. Buckland AG, Wilton DC. 2000a. Anionic phospholipids, interfacial binding and the regulation of cell functions. Biochim Biophys Acta 1483:199-216. (Pubitemid 30029053)
16. Buckland AG, Wilton DC. 2000b. The antibacterial properties of secreted phospholipases A2. Biochim Biophys Acta 1488: 71-82.
17. Buckland AG, Wilton DC. 2003. Annexins and phospholipases. In: Bandorowicz-Pikula J, editor. Annexins: Biological importance and annexin-related pathologies. New York: Kluwer Academic/Plenum Publishers, Landes Bioscience. pp 207-217.
18. Chander A,NaiduDG,ChenXL. 2006.Aten-residue domain (Y11-A20) in the NH2-terminus modulates membrane association of annexin A7. Biochim Biophys Acta 1761:775-784. (Pubitemid 44108753)
19. Chander A, Chen XL, Naidu DG. 2007. A role for diacylglycerol in annexin A7-mediated fusion of lung lamellar bodies. Biochim Biophys Acta 1771:1308-1318. (Pubitemid 47499232)
20. Chasserot-Golaz S, Vitale N, Umbrecht-Jenck E, Knight D, Gerke V, Bader MF. 2005. Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol Biol Cell 16:1108-1119. (Pubitemid 40349549)
21. Chen Z, Yoshihara E, Son A, Matsuo Y, Masutani H, Sugie K, et al. 2010. Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells. Immunol Lett 131:11-18.
22. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, et al. 2002. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21:5289-5300. (Pubitemid 34948140)
23. Chung YW, Oh HY, Kim JY, Kim JH, Kim IY. 2004. Allergeninduced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma. Proteomics 4:3328-3334.
24. Clarke CJ, Forman S, Pritchett J, Ohanian V, Ohanian J. 2008. Phospholipase C-d1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1. Am J Physiol Heart Circ Physiol 295: H826-H834.
25. Claus RA, Dorer MJ, Bunck AC, Deigner HP. 2009. Inhibition of sphingomyelin hydrolysis: Targeting the lipid mediator ceramide as a key regulator of cellular fate. Curr Med Chem 16:1978-2000.
26. Cmoch A, Strzelecka-Kiliszek A, Palczewska M, Groves P, Pikula S. 2011. Matrix vesicles isolated from mineralization-competent Saos-2 cells are selectively enriched with annexins and S100 proteins. Biochem Biophys Res Commun 412:683-687.
27. Cornely R, Rentero C, Enrich C, Grewal T, Gaus K. 2011. Annexin A6 is an organizer of membrane microdomains to regulate receptor localization and signalling. IUBMB Life 63:1009-1017.
28. Croxtall JD, Newman SP, Choudhury Q, Flower RJ. 1996a. The concerted regulation of cPLA2, COX2, and lipocortin 1 expression by IL-1 beta in A549 cells. Biochem Biophys Res Commun 220:491-495. (Pubitemid 26198541)
29. Croxtall JD, Choudhury Q, Newman S, Flower RJ. 1996b. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem Pharmacol 52:351-356. (Pubitemid 26233764)
30. Croxtall JD, Choudhury Q, Flower RJ. 1998. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: Identification of E-Q-E-Y-V as a crucial component. Br J Pharmacol 123:975-983. (Pubitemid 28085400)
31. Croxtall JD, Gilroy DW, Solito E, Choudhury Q, Ward BJ, Buckingham JC, et al. 2003. Attenuation of glucocorticoid functions in an Anx-A1-/-cell line. Biochem J 371:927-935. (Pubitemid 36578891)
32. Cubells L, Vilà de Muga S, Tebar F, Wood P, Evans R, Ingelmo-Torres M, et al. 2007. Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex. Traffic 8:1568-1589. (Pubitemid 47578362)
33. Cubells L, Vilà de Muga S, Tebar F, Bonventre JV, Balsinde J, Pol A, et al. 2008. Annexin A6-induced inhibition of cytoplasmic phospholipase A2 is linked to caveolin-1 export from the Golgi. J Biol Chem 283:10174-10183.
34. Damazo AS, Moradi-Bidhendi N, Oliani SM, Flower RJ. 2007. Role of annexin 1 gene expression in mouse craniofacial bone development. Birth Defects Res A Clin Mol Teratol 79:524-532. (Pubitemid 47068188)
35. De Caterina R, Sicari R, Giannessi D, Paggiaro PL, Paoletti P, Lazzerini G, et al. 1993. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 75:2368-2375. (Pubitemid 24008347)
36. De Diego I, Schwartz F, Siegfried H, Dauterstedt P, Heeren J, Beisiegel U, et al. 2002. Cholesterol modulates the membrane binding and intracellular distribution of annexin 6. J Biol Chem 277:32187-32194. (Pubitemid 34969033)
37. Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. 2011. Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111:6130-6185.
38. DomonMM,MatarG, Strzelecka-Kiliszek A, Bandorowicz-Pikula J, Pikula S, Besson F. 2010. Interaction of annexin A6 with cholesterol rich membranes is pH-dependent and mediated by the sterol OH. J Colloid Interface Sci 346:436-441.
39. Domon MM, Besson F, Bandorowicz-Pikula J, Pikula S. 2011. Annexin A6 is recruited into lipid rafts of Niemann-Pick type C disease fibroblasts in a Ca2+-dependent manner. Biochem Biophys Res Commun 405:192-196.
40. Domon MM, Nasir MN, Matar G, Pikula S, Besson F, Bandorowicz-Pikula J. 2012. Annexins as organizers of cholesterol-and spingomyelin-enriched membrane microdomains in Niemann-Pick type C disease. Cell Mol Life Sci 69:1773-1785.
41. Dong Q, Patel M, Scott KF, Graham GG, Russell PJ, Sved P. 2006. Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett 240:9-16. (Pubitemid 44037166)
42. Draeger A, Monastyrskaya K, Babiychuk EB. 2011. Plasma membrane repair and cellular damage control: The annexin survival kit. Biochem Pharmcol 81:703-712.
43. Enrich C, Rentero C, de Muga SV, Reverter M, Mulay V, Wood P, et al. 2011. Annexin A6-linking Ca2+ signaling with cholesterol transport. Biochim Biophys Acta 1813: 935-947.
44. Fang Z, Takizawa N, Wilson KA, Smith TC, Delprato A, Davidson MW, et al. 2010. The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility. Traffic 11:782-799.
45. Fatimathas L, Moss SE. 2010. Annexins as disease modifiers. Histol Histopathol 25:527-532.
46. Faugaret D, Chouinard FC, Harbour D, El azreq MA, Bourgoin SG. 2011. An essential role for phospholipase D in the recruitment of vesicle amine transport protein-1 to membranes in human neutrophils. Biochem Pharmacol 81:144-156.
47. Flood EC, Hajjar KA. 2011. The annexin A2 system and vascular homeostasis. Vascul Pharmacol 54:59-67.
48. Flower RJ, Blackwell GJ. 1979. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456-459. (Pubitemid 9130706)
49. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, et al. 2004. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560-569. (Pubitemid 38160786)
50. Fukami K, Inanobe S, Kanemaru K, Nakamura Y. 2010. Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog Lipid Res 49:429-437.
51. Futter CE, White IJ. 2007. Annexins and endocytosis. Traffic 8:951-958. (Pubitemid 47074030)
52. Futter CE, Felder S, Schlessinger J, Ullrich A, Hopkins CR. 1993. Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J Cell Biol 120:77-83. (Pubitemid 23014068)
53. Galan C, Woodard GE, Dionisio N, Salido GM, Rosado JA. 2010. Lipid rafts modulate the activation but not the maintenance of store-operated Ca2+ entry. Biochim Biophys Acta 1803: 1083-1093.
54. Ganapathi SB, Fox TE, Kester M, Elmslie KS. 2010. Ceramide modulates HERG potassium channel gating by translocation into lipid rafts. Am J Physiol Cell Physiol 299: C74-C86.
55. Gao X, Lowry PR, Zhou X, Depry C, Wei Z, Wong GW, et al. 2011. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci USA 108:14509-14514.
56. Gentil-dit-Maurin A, Oun S, Almagro S, Bouillot S, Courçon M, Linnepe R, et al. 2010. Unraveling the distinct distributions of VE-and N-cadherins in endothelial cells: A key role for p120-catenin. Exp Cell Res 316:2587-2599.
57. Gerke V, Moss SE. 2002. Annexins: From structure to function. Physiol Rev 82:331-371. (Pubitemid 34654456)
58. Gerke V, Creutz CE, Moss SE. 2005. Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6:449-461. (Pubitemid 40780557)
59. Goebeler V, Ruhe D, Gerke V, Rescher U. 2006. Annexin A8 displays unique phospholipid and F-actin binding properties. FEBS Lett 580:2430-2434.
60. Gokhale NA, Abraham A, Digman MA, Gratton E, Cho W. 2005. Phosphoinositide specificity of and mechanism of lipid domain formation by annexin A2-p11 heterotetramer. J Biol Chem 280:42831-42840. (Pubitemid 43049245)
61. Grewal T, Enrich C. 2009. Annexins-modulators of EGF receptor signalling and trafficking. Cell Signal 21:847-858.
62. Grewal T, Heeren J, Mewawala D, Schnitgerhans T, Wendt D, Salomon G, et al. 2000. Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J Biol Chem 275:33806-33813.
63. Grewal T, Koese M, Rentero C, Enrich C. 2010. Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasis. Int J Biochem Cell Biol 42:580-584.
64. Harrist AV, Ryzhova EV, Harvey T, González-Scarano F. 2009. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells. PLoS One 4:e5020.
65. Hayashi J, Liu P, Ferguson SE, Wen M, Sakata T, Teraoka H, et al. 1993. Arachidonic acid metabolism in cells transfected with sense and antisense cDNA to annexin-1. Biochem Mol Biol Int 31:143-151. (Pubitemid 23300271)
66. Hayes MJ, Rescher U, Gerke V, Moss SE. 2004a. Annexin-actin interactions. Traffic 5:571-576. (Pubitemid 39144487)
67. Hayes MJ, Merrifield CJ, Shao D, Ayala-Sanmartin J, Schorey CD, Levine TP, et al. 2004b. Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway. J Biol Chem 279:14157-14164. (Pubitemid 38468952)
68. Hayes MJ, Shao D, Bailly M, Moss SE. 2006. Regulation of actin dynamics by annexin 2. EMBO J 25:1816-1826.
69. Hayes MJ, Longbottom RE, Evans MA, Moss SE. 2007. Annexinopathies. Subcell Biochem 45:1-28.
70. Hayes MJ, Shao DM, Grieve A, Levine T, Bailly M, Moss SE. 2009. Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate. Biochim Biophys Acta 1793:1086-1095.
71. He KL, Sui G, Xiong H, Broekman MJ, Huang B, Marcus AJ, et al. 2011. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem 286:15428-15439.
72. Herbert SP, Odell AF, Ponnambalam S, Walker JH. 2007. The confluence-dependent interaction of cytosolic phospholipase A2-alpha with annexin A1 regulates endothelial cell prostaglandin E2 generation. J Biol Chem 282:34468-34478.
73. Hirabayashi T, Murayama T, Shimizu T. 2004. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 27:1168-1173. (Pubitemid 41701705)
74. Hofmann A, Osman A, Leow CY, Driguez P, McManus DP, Jones MK. 2010. Parasite annexins-new molecules with potential for drug and vaccine development. Bioessays 32:967-976.
75. Hummel I Klappe K, Ercan C, Kok JW. 2011. Multidrug resistance-related protein 1 (MRP1) function and localization depend on cortical actin. Mol Pharmacol 79:229-240.
76. Illien F, Finet S, Lambert O, Ayala-Sanmartin J. 2010. Different molecular arrangements of the tetrameric annexin 2 modulate the size and dynamics of membrane aggregation. Biochim Biophys Acta 1798:1790-1796.
77. Jenkins RW, Canals D, Hannun YA. 2009. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21:836-846.
78. Jin S, Zhou F. 2009. Lipid raft redox signaling platforms in vascular dysfunction: Features and mechanisms. Curr Atheroscler Rep 11:220-226.
79. Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L. 2003. 1a,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes. J Invest Dermatol 120:561-570. (Pubitemid 36343998)
80. Kaetzel MA, Dedman JR. 1995. Annexins: Novel Ca2+-dependent regulators of membrane function. News Physiolog Sci 10:171-176.
81. Kaetzel MA, Dedman JR. 2004. Annexin VI regulation of cardiac function. Biochem Biophys Res Commun 322:1171-1177. (Pubitemid 39164647)
82. Kanaho Y, Suzuki T. 2002. Phosphoinositide kinases as enzymes that produce versatile signaling lipids, phosphoinositides. J Biochem 131:503-509. (Pubitemid 34456604)
83. Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, Anderson RL, et al. 2011. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J 25:483-496.
84. Kim KM, Kim DK, Park YM, Kim CK, Na DS. 1994. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 343:251-255. (Pubitemid 24136523)
85. Kim S, Ko J, Kim JH, Choi EC, Na DS. 2001a. Differential effects of annexins I, II, III, and V on cytosolic phospholipase A2 activity: Specific interaction model. FEBS Lett 489:243-248. (Pubitemid 32126417)
86. Kim SW, Rhee HJ, Ko J, Kim YJ, Kim HG, Yang JM, et al. 2001b. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J Biol Chem 276:15712-15719.
87. Kiyanagi T, Iwabuchi K, Shimada K, Hirose K, Miyazaki T, Sumiyoshi K, et al. 2011. Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis 215:60-69.
88. Konopka-Postupolska D, Clark G, Hofmann A. 2011. Structure, function and membrane interactions of plant annexins: An update. Plant Sci 181:230-241.
89. Lafont F, Lecat S, Verkade P, Simons K. 1998. Annexin XIIIb associates with lipid microdomains to function in apical delivery. J Cell Biol 142:1413-1427. (Pubitemid 28452593)
90. Lambert O, Cavusoglu N, Gallay J, Vincent M, Rigaud JL, Henry JP, et al. 2004. Novel organization and properties of annexin 2-membrane complexes. J Biol Chem 279:10872-10882. (Pubitemid 38401577)
91. Laohavisit A, Davies JM. 2011. Annexins. New Phytol 189:40-53.
92. Lasley RD. 2011. Adenosine receptors and membrane microdomains. Biochim Biophys Acta 1808:1284-1289.
93. Lecat S, Verkade P, Thiele C, Fiedler K, Simons K, Lafont F. 2000. Different properties of two isoforms of annexin XIII in MDCK cells. J Cell Sci 113:2607-2618. (Pubitemid 30599412)
94. Lemmon MA. 2008. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 9:99-111. (Pubitemid 351158910)
95. Leslie CC, Gangelhoff TA, Gelb MH. 2010. Localization and function of cytosolic phospholipase A2alpha at the Golgi. Biochimie 92:620-626.
96. Levental I, Grzybek M, Simons K. 2010. Greasing their way: Lipid modifications determine protein association with membrane rafts. Biochemistry 49:6305-6316.
97. Lim LH, Pervaiz S. 2007. Annexin 1: The new face of an old molecule. FASEB J 21:968-975. (Pubitemid 46495688)
98. Lin S, Wang XM, Nadeau PE, Mergia A. 2010. HIV infection upregulates caveolin 1 expression to restrict virus production. J Virol 84:9487-9496.
99. Liu J, Zhu X, Myo S, Lambertino AT, Xu C, Boetticher E, et al. 2005. Glucocorticoid-induced surface expression of annexin 1 blocks beta2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein. J Allergy Clin Immunol 115:493-500. (Pubitemid 40341701)
100. Mahimainathan L, Choudhury GG. 2004. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 279:15258-15268. (Pubitemid 38618922)
101. Martin-Belmonte F, Mostov K. 2007. Phosphoinositides control epithelial development. Cell Cycle 6:1957-1961.
102. Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, et al. 2007. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128:383-397. (Pubitemid 46123512)
103. Matsunaga T, Inaba T, Matsui H, Okuya M, Miyajima A, Inukai T, et al. 2004. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein. Blood 103:3185-3191. (Pubitemid 38451697)
104. Mayran N, Parton RG, Gruenberg J. 2003. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 22:3242-3253. (Pubitemid 36834855)
105. McDermott M, Wakelam MJ, Morris AJ. 2004. Phospholipase D. Biochem Cell Biol 82:225-253. (Pubitemid 38580885)
106. Meliton AY, Munoz NM, Zhu X, Leff AR. 2008. Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks beta 2-integrin adhesion in neutrophils. J Leukoc Biol 83:344-351. (Pubitemid 351225615)
107. Monastyrskaya K, Babiychuk EB, Hostettler A, Rescher U, Draeger A. 2007. Annexins as intracellular calcium sensors. Cell Calcium 41:207-219. (Pubitemid 46201502)
108. Monastyrskaya K, Babiychuk EB, Hostettler A, Wood P, Grewal T, Draeger A. 2009a. Plasma membrane-associated annexin A6 reduces Ca2+ entry by stabilizing the cortical actin cytoskeleton. J Biol Chem 284:17227-17242.
109. Monastyrskaya K, Babiychuk EB, Draeger A. 2009b. The annexins: Spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci 66:2623-2642.
110. Morel E, Parton R, Gruenberg J. 2009. Annexin A2-dependent polymerization of actin mediates endosome biogenesis. Dev Cell 16:445-457.
111. Morgan RO, Martin-Almedina S, Iglesias JM, Gonzalez-Florez MI, Fernandez MP. 2004. Evolutionary perspective on annexin calcium-binding domains. Biochim Biophys Acta 1742:133-140. (Pubitemid 39601773)
112. Morgan RO, Martin-Almedina S, Garcia M, Jhoncon-Kooyip J, Fernandez MP. 2006. Deciphering function and mechanism of calcium-binding proteins from their evolutionary imprints. Biochim Biophys Acta 1763:1238-1249. (Pubitemid 44779869)
113. Muimo R. 2009. Regulation of CFTR function by annexin A2-S100A10 complex in health and disease. Gen Physiol Biophys 28:F14-F19.
114. Mussunoor S, Murray GI. 2008. The role of annexins in tumour development and progression. J Pathol 216:131-140.
115. Nadiri A, Polyak MJ, Jundi M, Alturaihi H, Reyes-Moreno C, Hassan GS, et al. 2011. CD40 translocation to lipid rafts: Signaling requirements and downstream biological events. Eur J Immunol 41:2358-2367.
116. Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496.
117. Parente L, Solito E. 2004. Annexin 1: More than an anti-phospholipase protein. Inflamm Res 53:125-132. (Pubitemid 38526595)
118. Paris L, Cecchetti S, Spadaro F, Abalsamo L, Lugini L, Pisanu ME, et al. 2010. Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells. Breast Cancer Res 12:R27.
119. Potez S, Luginbühl M, Monastyrskaya K, Hostettler A, Draeger A, Babiychuk EB. 2011. Tailored protection against plasmalemmal injury by annexins with different Ca2+ sensitivities. J Biol Chem 286:17982-17991.
120. Rescher U, Ruhe D, Ludwig C, Zobiack N, Gerke V. 2004. Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J Cell Sci 117:3473-3480. (Pubitemid 39206387)
121. Reverter M, Rentero C, de Muga SV, Alvarez-Guaita A, Mulay V, Cairns R, et al. 2011. Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function. Mol Biol Cell 22:4108-4123.
122. Rezvanpour A, Santamaria-Kisiel L, Shaw GS. 2011. The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair. J Biol Chem 286:40174-40183.
123. Riquelme G, Llanos P, Tischner E, Neil J, Campos B. 2004. Annexin 6 modulates the maxi-chloride channel of the apical membrane of syncytiotrophoblast isolated from human placenta. J Biol Chem 279:50601-50608. (Pubitemid 39577877)
124. Rivera R, Chun J. 2008. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol 160:25-46.
125. Rosenbaum S, Kreft S, Etich J, Frie C, Stermann J, Grskovic I, et al. 2011. Identification of novel binding partners (annexins) for the cell death signal phosphatidylserine and definition of their recognition motif. J Biol Chem 286:5708-5716.
126. Russo-Marie F. 1999. Annexin V and phospholipid metabolism. Clin Chem Lab Med 37:287-291. (Pubitemid 29209743)
127. Saavedra G, Zhang W, Peterson B, Cummings BS. 2006. Differential roles for cytosolic and microsomal Ca2+-independent phospholipase A2 in cell growth and maintenance of phospholipids. J Pharmacol Exp Ther 318:1211-1219. (Pubitemid 44268328)
128. Sakaguchi M, Murata H, Sonegawa H, Sakaguchi Y, Futami J, Kitazoe M, et al. 2007. Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J Biol Chem 282:35679-35686. (Pubitemid 350277150)
129. Schiffmann R. 2010. Therapeutic approaches for neuronopathic lysosomal storage disorders. J Inherit Metab Dis 33:373-379.
130. Schuchman EH. 2010. Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann-Pick disease. FEBS Lett 584:1895-1900.
131. Schug ZT, Frezza C, Galbraith LC, Gottlieb E. 2012. The music of lipids: How lipid composition orchestrates cellular behaviour. Acta Oncol 51:301-310.
132. Schutters K, Reutelingsperger C. 2010. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 15:1072-1082.
133. Seaton BA, Dedman JR. 1998. Annexins. Biometals 11:399-404. (Pubitemid 29123016)
134. Selvy PE, Lavieri RR, Lindsley CW, Brown HA. 2011. Phospholipase D: Enzymology, functionality, and chemical modulation. Chem Rev 111:6064-6119.
135. Skrahina T, Piljić A, Schultz C. 2008. Heterogeneity and timing of translocation and membrane-mediated assembly of different annexins. Exp Cell Res 314:1039-1047.
136. Sohma H, Creutz CE, Gasa S, Ohkawa H, Akino T, Kuroki Y. 2001. Differential lipid specificities of the repeated domains of annexin IV. Biochim Biophys Acta 1546:205-215. (Pubitemid 32217817)
137. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. 2001. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 133:217-228. (Pubitemid 32514504)
138. Sones WR, Davis AJ, Leblanc N, Greenwood IA. 2010. Cholesterol depletion alters amplitude and pharmacology of vascular calcium-activated chloride channels. Cardiovasc Res 87:476-484.
139. Staubach S, Hanisch FG. 2011. Lipid rafts: Signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 8:263-277.
140. Surma MA, Klose C, Simons K. 2011. Lipid-dependent protein sorting at the trans-Golgi network. Biochim Biophys Acta; DOI: 10.1016/j.bbalip.2011.12.008.
141. Sztolsztener ME, Strzelecka-Kiliszek A, Pikula S, Tylki-Szymanska A, Bandorowicz-Pikula J. 2010. Cholesterol as a factor regulating intracellular localization of annexin A6 in Niemann-Pick type C human skin fibroblasts. Arch Biochem Biophys 493:221-233.
142. te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, Platt FM, et al. 2004. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J Biol Chem 279: 26167-26175. (Pubitemid 38798762)
143. Tamasawa N, Takayasu S, Murakami H, Yamashita M, Matsuki K, Tanabe J, et al. 2012. Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation. J Clin Lipidol 6:74-80.
144. Tian W, Wijewickrama GT, Kim JH, Das S, Tun MP, Gokhale N, et al. 2008. Mechanism of regulation of group IVA phospholipase A2 activity by Ser727 phosphorylation. J Biol Chem 283:3960-3971.
145. Torosyan Y, Dobi A, Naga S, Mezhevaya K, Glasman M, Norris C, et al. 2006. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription. Cancer Res 66: 9609-9616. (Pubitemid 44623660)
146. Torosyan Y, Simakova O, Naga S, Mezhevaya K, Leighton X, Diaz J, et al. 2009. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and-resistant prostate cancer cells. Int J Cancer 125:2528-2539.
147. Umbrecht-Jenck E, Demais V, Calco V, Bailly Y, Bader MF, Chasserot-Golaz S. 2010. S100A10-mediated translocation of annexin-A2 to SNARE proteins in adrenergic chromaffin cells undergoing exocytosis. Traffic 11:958-971.
148. Valapala M, Vishwanatha JK. 2011. Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J Biol Chem 286:30911-30925.
149. Vats K, Knutson K, Hinderliter A, Sheets ED. 2010. Peripheral protein organization and its influence on lipid diffusion in biomimetic membranes. ACS Chem Biol 5:393-403.
150. Vilá de Muga S, Timpson P, Cubells L, Evans R, Hayes TE, Rentero C, et al. 2009. Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 28:363-377.
151. White IJ, Bailey LM, Aghakhani MR, Moss SE, Futter CE. 2006. EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation. EMBO J 25:1-12. (Pubitemid 43077290)
152. Zhang C, Li PL. 2010. Membrane raft redox signalosomes in endothelial cells. Free Radic Res 44:831-842.
153. Zhang F, Sha J, Wood TG, Galindo CL, Garner HR, Burkart MF, et al. 2008. Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA. Cell Signal 20:844-861.
154. Zobiack N, Rescher U, Laarmann S, Michgehl S, Schmidt MA, Gerke V. 2002. Cell-surface attachment of pedestalforming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J Cell Sci 115:91-98. (Pubitemid 34105532)
155. Zobiack N, Rescher U, Ludwig C, Zeuschner D, Gerke V. 2003. The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes. Mol Biol Cell 14:4896-4908. (Pubitemid 37484805)
156. Zschörnig O, Opitz F, Müller M. 2007. Annexin A4 binding to anionic phospholipid vesicles modulated by pH and calcium. Eur Biophys J 36:415-424. (Pubitemid 46626219)